Entzündliche Grundlagen neuropsychiatrischer Störungen
暂无分享，去创建一个
[1] T. Gattringer,et al. Primäre Angiitis des Zentralnervensystems , 2022, psychopraxis. neuropraxis.
[2] D. Janigro,et al. GFAP and S100B: What You Always Wanted to Know and Never Dared to Ask , 2022, Frontiers in Neurology.
[3] P. Klivényi,et al. Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis , 2021, Reviews in the neurosciences.
[4] Zhijun Zhang,et al. Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis , 2020, European Neuropsychopharmacology.
[5] Volker Arolt,et al. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment , 2005, Psychopharmacology.
[6] M. Wiesmann,et al. S100B and response to treatment in major depression: a pilot study , 2003, European Neuropsychopharmacology.
[7] Manfred Herrmann,et al. Release of Glial Tissue–Specific Proteins After Acute Stroke: A Comparative Analysis of Serum Concentrations of Protein S-100B and Glial Fibrillary Acidic Protein , 2000, Stroke.
[8] B. Aouizerate,et al. Inflammatory Bases of Neuropsychiatric Symptom Domains: Mechanisms and Specificity , 2021, Immuno-Psychiatry.